Are you from the healthcare sector?

The content of the website shows medical devices and accessories. It is exclusively reserved to healthcare professionals (HCP). Please confirm you are a healthcare professional.

Disclaimer: This website is intended for healthcare professionals of the Europe, Middle East and Africa only. Approved uses of our medical devices may vary by country and region.

µTASWako™ i30

µTASWako™ i30

µTASWako™ i30 (Micro Total Analysis System) is the worldwide unique system for the automated measurement of the biomarkers AFP-L3 and DCP.

Product information

µTASWako™ i30 (Micro Total Analysis System) is the worldwide unique system for the automated measurement of the biomarkers AFP-L3 and DCP.

Both, AFP-L3 (lectin-reactive alpha-fetoprotein) and DCP (des-gamma-carboxy prothrombin), have been shown to be specific for risk assessment of the main primary liver cancer hepatocellular carcinoma (HCC).

µTASWako™ i30 integrates immunoassay steps in disposable, microfluidic microchips. Single tests can be performed in only 9 minutes.

Click here for more information for Health Care Providers.

Dimensions/Weight

Width: 520 mm
Depth: 600 mm
Height: 550 mm
Weight: 71 kg

Key Features

  • For in vitro diagnostic use
  • Electrokinetic Analyte Transport Assay (EATA)
  • High sensitive fluorescence detection
  • Available analytes: AFP/AFP-L3 and DCP
  • Assay precision less than 3% CV for AFP-L3
  • Throughput: 25 tests/h

Storage

Store µTASWako™ Chip Cassette and µTASWako™ Wash Solution at 2-35° C.

Safety Information

Health Hazard
Corrosive

Literature

For more information and the latest publications please visit Videos & Publications.

Are you interested in "µTASWako™ i30" and need more information?